Optimizing aerosolization of a high-dose L-arginine powder for pulmonary delivery
In this study a carrier-free dry powder inhalation (DPI) containing L-arginine (ARG) was developed. As such, it is proposed that ARG could be used for adjunctive treatment of cystic fibrosis and/or tuberculosis. Various processing methods were used to manufacture high-dose formulation batches consis...
Saved in:
Main Authors: | Satu Lakio (Author), David A.V. Morton (Author), Anna P. Ralph (Author), Pete Lambert (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of exhalation before the inhalation of dry powder aerosol drugs on the breathing parameters, emitted doses and aerosol size distributions
by: Árpád Farkas, et al.
Published: (2023) -
Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler
by: Yoen-Ju Son, et al.
Published: (2021) -
Feasibility of a High-Dose Inhaled Indomethacin Dry Powder with Dual Deposition for Pulmonary and Oral Delivery
by: Jamie E. Spahn, et al.
Published: (2024) -
Performance Testing of a Homemade Aerosol Generator for Pulmonary Administration of Dry Powder Formulations to Mice
by: Rick Heida, et al.
Published: (2023) -
Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
by: Zarogoulidis P, et al.
Published: (2014)